[144] The Cigna Group SEC Filing

Rhea-AI Filing Summary

Cigna Group (CI) submitted a Form 144 proposing the sale of 35,711 shares of its common stock, with an aggregate market value of $9,822,667.66, to be executed on 08/12/2025 through Fidelity Brokerage Services LLC on the NYSE. The filing lists total shares outstanding of 266,928,075 and shows the securities to be sold were acquired through option exercises and restricted stock vesting between 02/26/2021 and 08/12/2025, with some purchases paid in cash and others issued as compensation.

The filer reports no securities sold by the same person in the past three months and includes the standard attestation that the seller has no undisclosed material information; the notice is marked LIVE.

Insights

Securities Analyst

Planned insider sale of 35,711 shares valued at $9.82M; holdings largely from options and vesting.

The Form 144 documents a proposed sale executed through Fidelity on 08/12/2025 of 35,711 common shares with an aggregate value of $9,822,667.66. Acquisition details show multiple option grants (02/24/2021 and 02/23/2022), restricted stock vesting events from 2021 through 2025, and a stock option exercise on 05/15/2024. No sales by the same person are reported in the prior three months. This is a routine regulatory notice required before an insider sale.

Corporate Governance Expert

Routine Form 144 filing with attestation of no undisclosed material information and no recent sales reported.

The filing includes the customary signature representation that the seller does not possess material nonpublic information and references Rule 10b5-1 trading plans if applicable. The schedule details the provenance of the shares being sold (options, vesting, cash-paid exercises) and confirms the transaction will occur on the NYSE via Fidelity. From a governance perspective, the document fulfills disclosure obligations for an insider disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	35711	9822667.66	266928075	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Options Granted - 02/24/2021	Issuer			14052	08/12/2025	Cash
Common	08/12/2025	Options Granted - 02/23/2022	Issuer			14124	08/12/2025	Cash
Common	02/26/2021	Restricted Stock Vesting	Issuer			513	02/26/2021	Compensation
Common	09/14/2021	Restricted Stock Vesting	Issuer			1177	09/14/2021	Compensation
Common	02/25/2022	Restricted Stock Vesting	Issuer			1044	02/25/2022	Compensation
Common	03/01/2022	Restricted Stock Vesting	Issuer			674	03/01/2022	Compensation
Common	09/14/2022	Restricted Stock Vesting	Issuer			204	09/14/2022	Compensation
Common	09/14/2023	Restricted Stock Vesting	Issuer			1043	09/14/2023	Compensation
Common	03/01/2024	Restricted Stock Vesting	Issuer			1020	03/01/2024	Compensation
Common	05/15/2024	Stock Option Exercise	Issuer			875	05/15/2024	Cash
Common	03/01/2025	Restricted Stock Vesting	Issuer			985	03/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cigna (CI) Form 144 report?

The filing proposes the sale of 35,711 common shares with an aggregate market value of $9,822,667.66 to be sold on 08/12/2025 through Fidelity Brokerage Services LLC on the NYSE.

How were the securities being sold by the CI filer acquired?

The securities were acquired mainly via options granted (02/24/2021 and 02/23/2022), multiple restricted stock vesting events (2021–2025), and a stock option exercise on 05/15/2024.

Has the filer sold any Cigna securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account these securities are to be sold.

What attestations does the filer make in the Form 144?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 plans if applicable.

Through which broker and exchange will the sale be executed?

The proposed sale is to be executed via Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI on the NYSE.